Day One Biopharmaceuticals IDAWN
13F holders, Q2 2026 (June 30)1holders −207
0new positions
205sold out
$21.53avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Day One Biopharmaceuticals I (DAWN) in their 13F filings, down 207 from Q1 2026. 0 opened new positions and 205 sold out. The largest holder was IFP Advisors, Inc ($4K).
- Company
- Day One Biopharmaceuticals I
- CUSIP
- 23954D109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 205 | $1.8B |
All 13F filers, Q1 2026 → Q2 2026: 86,297,818 shares sold, net −86,297,818 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| IFP Advisors, Inc | 0.00% | Reduce -74.2% | 165 | $4K |
"% of holder's portfolio" is DAWN's weight in each manager's 13F, not the share of Day One Biopharmaceuticals I the manager owns.